Device / Technology News

RSS

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left… until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart.

9 May 2013

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.

9 May 2013

Abbott receives CE Mark for ARCHITECT HbA1c test

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.

9 May 2013

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

Precision Therapeutics, Inc., a life science company that develops personalized medicine products for individualizing cancer care, today announced that a clinical study which demonstrates the feasibility of the ChemoFx chemoresponse assay to identify patients unlikely to respond to first-line therapy has been accepted for presentation at the 2013 Annual Meeting of the Western Association of Gynecologic Oncologists.

9 May 2013

Quantum International develops medical testing software for Apple iPad

Cutting-edge technology company Quantum International Corp. announced today that it has begun development on an innovative new accessory for the Apple iPad that could potentially revolutionize mobile medical testing.

9 May 2013

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

More than 100,000 Geisinger Health System patients will have access to their doctors' notes for the first time through the secure MyGeisinger online patient portal when Geisinger expands OpenNotes in May due to the initiative's overwhelming success.

9 May 2013

Study suggests new application for endovascular grafts

Tumors have the potential to grow locally and invade neighboring organs. Some chest tumors may invade one of the great vessels of the body, the aorta. Surgical removal of these tumors is very challenging and necessitates the support of a heart-lung machine.

9 May 2013

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.

9 May 2013

ITM researchers develop, test a combination of tools to diagnose SN-TB

Researchers at the Institute of Tropical Medicine have successfully developed and tested a combination of simple clinical, radiological and laboratory tools to diagnose smear-negative tuberculosis.

9 May 2013

UCSF researchers find new genomic test to identify aggressive form of prostate cancer

A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.

9 May 2013

New technique can lead to effective use of nanoparticles as drug delivery system

A Wayne State University researcher has successfully tested a technique that can lead to more effective use of nanoparticles as a drug delivery system.

8 May 2013

Using copper IUD or coil does not exacerbate period pain, reveals study

Using a copper intrauterine device (IUD), or coil, does not exacerbate period pain, reveals a study where researchers from the Sahlgrenska Academy, University of Gothenburg, Sweden, followed 2,100 women for 30 years.

8 May 2013

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.

8 May 2013

Aviir to extend comprehensive inherited cardiovascular disease genetic test menu

Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced that it will be extending its offered services with comprehensive inherited cardiovascular disease genetic test menu.

8 May 2013

Prexion receives FDA approval for Eclipse 3D Cone Beam Computed Tomography Dental Scanner

Today, Prexion, Inc. announced FDA approval of the The Eclipse 3D Cone Beam Computed Tomography Dental Scanner.

8 May 2013

WHOI deploys new robotic sensor in Gulf of Maine coastal waters to monitor HABs

A new robotic sensor deployed by Woods Hole Oceanographic Institution in Gulf of Maine coastal waters may transform the way red tides or harmful algal blooms are monitored and managed in New England.

8 May 2013

New version of FRAX now available for 53 countries

An increasing number of physicians around the world are using FRAX-, a scientifically validated online fracture-risk calculator that has been developed by the World Health Organization Collaborating Centre for Metabolic Bone Diseases at the University of Sheffield, UK.

8 May 2013

$Study shows VATS-LCSD can help children with refractory cardiac arrhythmias$

Study shows VATS-LCSD can help children with refractory cardiac arrhythmias

Inherited ventricular arrhythmias are an important cause of morbidity and sudden cardiac death in children who have structurally normal hearts. Despite conventional medical therapy, some of these children remain symptomatic with recurrent life-threatening arrhythmias, syncope, or frequent discharges from implantable cardioverter defibrillators.

8 May 2013

Brain scan studies may provide clues about how the device improves depression

For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy.

8 May 2013

BIOTRONIK receives FDA approval for ICD/CRT-D series

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug Administration granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator series.

8 May 2013

Device / Technology News

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

Abbott receives CE Mark for ARCHITECT HbA1c test

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

Quantum International develops medical testing software for Apple iPad

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

Study suggests new application for endovascular grafts

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

ITM researchers develop, test a combination of tools to diagnose SN-TB

UCSF researchers find new genomic test to identify aggressive form of prostate cancer

New technique can lead to effective use of nanoparticles as drug delivery system

Using copper IUD or coil does not exacerbate period pain, reveals study

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Aviir to extend comprehensive inherited cardiovascular disease genetic test menu

Prexion receives FDA approval for Eclipse 3D Cone Beam Computed Tomography Dental Scanner

WHOI deploys new robotic sensor in Gulf of Maine coastal waters to monitor HABs

New version of FRAX now available for 53 countries

Study shows VATS-LCSD can help children with refractory cardiac arrhythmias

Brain scan studies may provide clues about how the device improves depression

BIOTRONIK receives FDA approval for ICD/CRT-D series

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News